FDA NDC Directory · JSON-LD · Markdown

Loxapine

NDC 0527-1396 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerLannett Company, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA090695
Dosage form / routeCAPSULE · ORAL
Active ingredientsLOXAPINE SUCCINATE (25 mg/1)
Marketing started20110926
Package count2

External sources

Source: openFDA. Public-domain (CC0).